Trade Summary

2 days ago, Thomas John Charles, serving as EVP, General Counsel at Krystal Biotech, Inc. (KRYS), sold 642 shares at $302.03 per share, for a total transaction value of $193,903.26.

This sale represents a 100.00% decrease in Thomas John Charles's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 5:17 PM ET, 1 day after the trade was made.

Krystal Biotech, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.